Jennifer Maynard

Technologies

• Innovative pH-selective antibody engineering for cancer therapy
• Treating respiratory diseases and whooping cough
• Dual-target defense: bispecific antibodies revolutionize pertussis toxin neutralization
• Engineered polypeptides for enhanced integrin binding and antigen delivery
• Monoclonal antibodies for the conserved feature of the coronavirus spike protein
• Engineered antibodies for enhanced immune response